Geoff Carr Fellowship
Applications for the 2026-2027 year are now closed
The Annual Lupus Ontario Geoff Carr Fellowship was established in 1990. The project is named for the late Geoff Carr, a member of the Association of Commercial Travellers, and a strong supporter of Lupus Ontario. The Fellowship year is served at an Ontario Lupus clinic. Since 1990, Lupus Ontario has funded the training of 35+ rheumatologists, the majority of them continue to practice in Ontario. The Fellowship is open to applicants from around the world with preference given to Canadians.
Goal of the Fellowship: to train a rheumatologist to become expert in diagnosing and treating lupus. The Fellow is also required to complete a research project.
Objectives of the Fellowship
- Learn best practices of diagnosing lupus.
- Learn best practices of treating lupus and of predicting and managing flares.
- Participate in a lupus research project.
The value of the Fellowship is described by some of the past Fellows.
Dr. Zahi Touma who currently leads the Lupus Clinic at Toronto Western Hospital states:
‘Supporting research is crucial, and one effective way to do this is through the Geoff Carr Fellowship. Research is essential for developing future lupus scientists, researchers, and healthcare professionals who manage lupus.’
Dr. Amanda Steiman, who currently leads the Young Adult SLE Clinic at Mount Sinai Hospital, Toronto, states:
“The Geoff Carr Lupus Research Fellowship supported my pursuit of advanced training in SLE. I emerged a stronger clinician, researcher and advocate for lupus patients. It allowed me to engage deeply with lupus care and research under the expert supervision of world leaders in the field, it and reinforced my passion for caring for patients with SLE.”
Dr. Barry Sheane, a lupus researcher in Ireland states:
“Lupus is becoming an increasingly treatable disease although challenges remain and there remains a significant shortfall in our knowledge of lupus-related pathology. Through the Geoff Carr Fellowship, rheumatologists with an interest in lupus can be facilitated in their pursuit of increasing our knowledge base with the ultimate goal of improving the quality of life of lupus sufferers.”
St. Joseph's Healthcare, London
Dr. Mais Nuaaman
Research focuses on improving care for patients with lupus nephritis by strengthening alignment between clinical practice and research and identifying risk factors that contribute to the disease.
Toronto Western Hospital
Dr.Justin Smith
Neuropsychiatric manifestations of SLE
Toronto Western Hospital
Dr. Teresa Semalulu
Exploring racial disparities in disease-related activity and damage in SLE.
SickKids Hospital
Dr. Stephanie Wong
Therapeutic drug monitoring of HCQ is feasible in the cSLE population, allowing for individualized HCQ treatment with optimal efficacy and prevention of long- term toxicity.
SickKids Hospital
Dr. Tala El Tal
Research focuses in neuropsychiatric (NPSLE), specifically examining the longitudinal prevalence of cognitive impairment and relationship to disease and health-related quality of life in cSLE.
Toronto Western Hospital
Dr. Ambika Gupta
Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.
Toronto Western Hospital
Dr. Laura Whittal Garcia
The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.
SickKids Hospital
Dr. Anita Dhanrajani
The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.
Toronto Western Hospital
Dr. Konstantinos Tselios
Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.
SickKids Hospital
Dr. Julie Couture
Depression in paediatric SLE patients.
Toronto Western Hospital
Dr. Konstantinos Tselios
The management of Arterial Hypertension and Hypercholesterolemia in patients with SLE. Are the current treatment guidelines adequate for lupus patients?
McMaster University
Dr. Kim Legault
Pathophysiology of cognitive dysfunction in patients with antiphospholipid antibodies and lupus.
Toronto Western Hospital
Dr. Barry Sheane
Cardio vascular risks in patients with SLE.
Toronto Western Hospital
Dr. Amanda Steiman
Predicting flares in patients who are serologically active and and clinically quiescent.
Dr. Zahi Touma
SRI-50 Index which is used to measure disease activity.
McMaster University
Dr. Derek Haaland
Lupus Nephritis.
SickKids Hospital
Dr. Satish Kumar
Long term outcome of children with SLE with emphasis on the Central Nervous System
Toronto Western Hospital
Dr. Zahi Touma
Outcome measures used in clinical trials in SLE in order to find an optimal measure.
Toronto Western Hospital
Dr. Desiree Tulloch-Reid
Lupus Nephritis.
Dr. Mandana Nikpour
Atherscerlosis in SLE
Toronto Western Hospital
Dr. Zhaleh Shariati
Definition of thrombitis risk associated with anticardiolipin antibofy in SLE
Toronto Western Hospital
Dr. Mandana Nikpour
Vascular disease in systemic Lupus Erythematosus
SickKids Hospital
Dr. Susanne Benseler
Methods to improve paediatric Lupus treatment.
Toronto Lupus Clinic
Dr. Adrienne Williamson
Dr. Marie Feletar
Impact of the updated 1997 revised criteria for classification of SLE, Prolonged remission in SLE
Toronto Lupus Clinic
Dr. Dana Jerome
The effective of menopause on disease activity in SLE
Dr. Anna Jaroszynska
Bone mineral density in premenopausal females with SLE
Toronto Lupus Clinic
Dr. Santiago Aguero
SickKids Hospital
Dr. Stefan Hagelberg
Pathogenic mechanisms in lupus patients with CNS involvement
University of Toronto
Dr. Ian Bruce
Assess the prevalence of ischemic heart disease in patients with SLE, current management of risk factors for coronary artery disease
McMaster University
Dr. Sergio Toloza
The Wellesley Hospital / University of Toronto
Dr. Vandana Chaudry
Osteonecrosis in SLE
The Wellesley Hospital / University of Toronto
Dr. Mahmood Abu-Shakra
- Anticardiolipin Antibodies in SLE: Clinical and Laboratory Correlations
- The Significance of Anticardiolipin Antibodies in patients with Lupus Nephritis
The Wellesley Hospital / University of Toronto
Dr. Julie Kovacs
Single Photon Emission Computerized Tomography (SPECT) in Neuropsychiatric SLE
The Wellesley Hospital / University of Toronto
Dr. Rachel Pauzner
- Prolactin in SLE
- Anti-neutrophil Cytoplasmic Antibodies (ANCA) in SLE
- Evaluation of predictive factors for neurocognitive dysfunction in patients with SLE
The Wellesley Hospital / University of Toronto
Dr. Barbara Walz-Leblanc
Serologically Active Clinically Quiescent Systemic Lupus Erythematosus (SLE) - Predictors of Clinical Flares